CORESTEMCHEMON Inc.
Develops stem cell therapies and provides non-clinical CRO preclinical services.
166480 | KO
Overview
Corporate Details
- ISIN(s):
- KR7166480004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로255번길 24 (삼평동), 성남시
Description
CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-19 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 400.6 KB | ||
| 2022-09-15 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 52.4 KB | ||
| 2022-09-15 00:00 |
[기재정정]투자설명서
|
Korean | 2.8 MB | ||
| 2022-09-15 00:00 |
[기재정정]주주총회소집결의
|
Korean | 28.7 KB | ||
| 2022-09-06 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 51.9 KB | ||
| 2022-09-06 00:00 |
[기재정정]투자설명서
|
Korean | 2.8 MB | ||
| 2022-09-05 00:00 |
투자설명서
|
Korean | 2.8 MB | ||
| 2022-08-24 00:00 |
[기재정정]증권신고서(합병)
|
Korean | 2.8 MB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1019.0 KB | ||
| 2022-08-16 00:00 |
주권매매거래정지(합병)
|
Korean | 4.7 KB | ||
| 2022-08-16 00:00 |
주요사항보고서(회사합병결정)
|
Korean | 46.1 KB | ||
| 2022-08-16 00:00 |
증권신고서(합병)
|
Korean | 2.8 MB | ||
| 2022-08-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 5.7 KB | ||
| 2022-08-16 00:00 |
[첨부추가]주주총회소집결의
|
Korean | 18.8 KB | ||
| 2022-08-08 00:00 |
투자판단관련주요경영사항(근위축성측삭경화증(루게릭병) 환자를 대상으로 HypoThermosol® FRS (HTS-FRS)를 현탁화제로 혼합한 뉴…
|
Korean | 9.8 KB |
Automate Your Workflow. Get a real-time feed of all CORESTEMCHEMON Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CORESTEMCHEMON Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CORESTEMCHEMON Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
